Year |
Citation |
Score |
2023 |
Payton M, Belmontes B, Hanestad K, Moriguchi J, Chen K, McCarter JD, Chung G, Ninniri MS, Sun J, Manoukian R, Chambers S, Ho SM, Kurzeja RJM, Edson KZ, Dahal UP, ... ... Bourbeau MP, et al. Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers. Nature Cancer. PMID 38151625 DOI: 10.1038/s43018-023-00699-5 |
0.301 |
|
2020 |
Frohn M, Liu L, Siegmund AC, Qian W, Amegadzie A, Chen N, Tan H, Hickman D, Wood S, Wen PH, Bartberger MD, Whittington DA, Allen JR, Bourbeau MP. The development of a structurally distinct series of BACE1 inhibitors via the (Z)-fluoro-olefin amide bioisosteric replacement. Bioorganic & Medicinal Chemistry Letters. 30: 127240. PMID 32527542 DOI: 10.1016/J.Bmcl.2020.127240 |
0.307 |
|
2014 |
Bourbeau MP, Ashton KS, Yan J, St Jean DJ. Nonracemic synthesis of GK-GKRP disruptor AMG-3969. The Journal of Organic Chemistry. 79: 3684-7. PMID 24678849 DOI: 10.1021/Jo500336E |
0.341 |
|
2014 |
Kocienski P, Bourbeau MP, Ashton KS, Yan J, Jean DJS. Synthesis of GK–GKRP Disruptor AMG-3969 Synfacts. 10: 671-671. DOI: 10.1055/S-0034-1378236 |
0.352 |
|
2013 |
Bailis J, Fang L, Orf J, Heller S, Bush T, Bourbeau M, Escobar S, Frohn M, Harrington P, Hsieh F, Pickrell A, Sham K, Siegmund A, Tan H, Zalameda L, et al. Abstract 711: Small molecule compounds that target cell division cycle 7 (Cdc7) kinase inhibit cell proliferation and tumor growth. Cancer Research. 73: 711-711. DOI: 10.1158/1538-7445.Am2013-711 |
0.372 |
|
2010 |
Zeng Q, Allen JG, Bourbeau MP, Wang X, Yao G, Tadesse S, Rider JT, Yuan CC, Hong FT, Lee MR, Zhang S, Lofgren JA, Freeman DJ, Yang S, Li C, et al. Azole-based inhibitors of AKT/PKB for the treatment of cancer. Bioorganic & Medicinal Chemistry Letters. 20: 1559-64. PMID 20137943 DOI: 10.1016/J.Bmcl.2010.01.067 |
0.301 |
|
2010 |
Zeng Q, Bourbeau MP, Wohlhieter GE, Yao G, Monenschein H, Rider JT, Lee MR, Zhang S, Lofgren J, Freeman D, Li C, Tominey E, Huang X, Hoffman D, Yamane H, et al. 2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeutics. Bioorganic & Medicinal Chemistry Letters. 20: 1652-6. PMID 20137932 DOI: 10.1016/J.Bmcl.2010.01.046 |
0.312 |
|
2006 |
Bourbeau MP, Rider JT. A convenient synthesis of 4-alkyl-5-aminoisoxazoles. Organic Letters. 8: 3679-80. PMID 16898790 DOI: 10.1021/Ol061260+ |
0.313 |
|
2006 |
Marshall JA, Mikowski AM, Bourbeau MP, Schaaf GM, Valeriote F. Leptostatin: a synthetic hybrid of the cytotoxic polyketides callystatin A and leptomycin B. Bioorganic & Medicinal Chemistry Letters. 16: 320-3. PMID 16271470 DOI: 10.1016/J.Bmcl.2005.09.084 |
0.344 |
|
2003 |
Marshall JA, Bourbeau MP. Synthesis of enantioenriched propargylic alcohols related to polyketide natural products. A comparison of methodologies. Organic Letters. 5: 3197-9. PMID 12943386 DOI: 10.1021/Ol034918H |
0.489 |
|
2003 |
Marshall JA, Bourbeau MP. Directed Pd(0)-catalyzed hydrostannations of internal alkynes Tetrahedron Letters. 44: 1087-1089. DOI: 10.1016/S0040-4039(02)02660-6 |
0.4 |
|
2002 |
Marshall JA, Bourbeau MP. Second-generation synthesis of the polypropionate subunit of callystatin A based on regioselective internal alkyne hydrostannation. Organic Letters. 4: 3931-4. PMID 12599495 DOI: 10.1021/Ol026791M |
0.473 |
|
2002 |
Marshall JA, Bourbeau MP. Total synthesis of (-)-callystatin A. The Journal of Organic Chemistry. 67: 2751-4. PMID 11975524 DOI: 10.1021/Jo016025D |
0.463 |
|
Show low-probability matches. |